Growth arrest associated with 12-o-tetradecanoylphorbol-13-acetate-induced hematopoietic differentiation with a defective retinoblastoma tumor suppressor-mediated pathway

Leukemia Research

Volumn 22, Issue 5, 1998, Pages 413-420

  Uchimaru, Kaoru ^a   Taniguchi, Toshiyasu ^a   Yoshikawa, Miwa ^a   Fujinuma, Haruko ^a   Fujita, Toshiro ^a   Motokura, Toru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cell cycle; Differentiation; p21 SD11 WAF1 CIP1; p27 KIP1; Retinoblastoma; TPA; Tumor suppressor

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P21;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; GROWTH DISORDER; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; FLOW CYTOMETRY; GENE EXPRESSION; GENES, RETINOBLASTOMA; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MEGAKARYOCYTES; MICROTUBULE-ASSOCIATED PROTEINS; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; S PHASE; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032077413     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00004-6     Document Type: Article

References (37)

1. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1059.
2. Sherr C.J. G1 phase progression: cycling on cue. Cell. 79:1994;551.
3. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323.
4. Matsuoka S., Edwards M.C., Bai C.et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:1995;650.
5. Halevy O., Novitch B.G., Spicer D.B.et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 267:1995;1018.
6. Parker S.B., Eichele G., Zhang P.et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science. 267:1995;1024.
7. Asiedu C., Biggs J., Lilly M., Kraft A.S. Inhibition of leukemic cell growth by the protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2. Cancer Res. 55:1995;3716.
8. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397.
9. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701.
10. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805.
11. Ogura M., Morishima Y., Ohno R.et al. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood. 66:1985;1384.
12. Motokura T., Bloom T., Kim H.G.et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 350:1991;512.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156.
14. Pines J., Hunter T. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell. 58:1989;833.
15. Pines J., Hunter T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature. 346:1990;760.
16. Lew D.J., Dulic V., Reed S.I. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell. 66:1991;1197.
17. Motokura T., Keyomarsi K., Kronenberg H.M., Arnold A. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chem. 267:1992;20412.
18. Palmero I., Holder A., Sinclair A.J., Dickson C., Peters G. Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene. 8:1993;1049.
19. Plumb M., Stein J., Stein G. Coordinate regulation of multiple histone mRNAs during the cell cycle in HeLa cells. Nucleic Acids Res. 11:1983;2391.
20. Poncz M., Eisman R., Heidenreich R.et al. Structure of the platelet membrane glycoprotein IIb. Homology to the alpha subunits of the vitronectin and fibronectin membrane receptors. J Biol Chem. 262:1987;8476.
21. Noda A., Ning Y., Venable S.F., Pereira-Smith O.M., Smith J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res. 211:1994;90.
22. Polyak K., Lee M.H., Erdjument-Bromage H.et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:1994;59.
23. Harlow E, Lane D. Antibodies: a Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1988:471.
24. Koff A., Cross F., Fisher A.et al. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell. 66:1991;1217.
25. Koff A., Giordano A., Desai D.et al. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science. 257:1992;1689.
26. Matsushime H., Quelle D.E., Shurtleff S.A., Shibuya M., Sherr C.J., Kato J.Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol. 14:1994;2066.
27. Ogura M., Morishima Y., Okumura M.et al. Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01s) by phorbol diesters. Blood. 72:1988;49.
28. Dulic V., Lees E., Reed S.I. Association of human cyclin E with a periodic G1-S phase protein kinase. Science. 257:1992;1958.
29. Schwaller J., Koeffler H.P., Niklaus G.et al. Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest. 95:1995;973.
30. Steinman R.A., Hoffman B., Iro A., Guillouf C., Liebermann D.A., el-Houseini M.E. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene. 9:1994;3389.
31. Zhang W., Grasso L., McClain C.D.et al. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 55:1995;668.
32. Dimri G.P., Nakanishi M., Desprez P.-Y., Simth J.R., Campisi J. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol Cel Biol. 16:1996;2987.
33. Flores-Rozas H., Kelman Z., Dean F.B.et al. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci USA. 91:1994;8655.
34. Waga S., Hannon G.J., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:1994;574.
35. García P., Calés C. Endoreplication in megakaryoblastic cell lines is accompanied by sustained expression of G1/S cyclins and downregulation of cdc25C. Oncogene. 13:1996;695.
36. Deng C., Zhang P., Harper J.W., Elledge S.J., Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675.
37. Wang Q.M., Jones J.B., Studzinski G.P. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 56:1996;264.